Vets' Meds Cost More: FDA Animal Drug Fees 2026
Published Date: 7/30/2025
Notice
Summary
The FDA is setting new fees for animal drug companies to pay in fiscal year 2026. If you make or sponsor animal drugs, expect some updated costs and clear payment rules starting October 1, 2025. These fees help the FDA review animal drug applications faster and keep our furry and farm friends safe and healthy.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
New FY2026 Animal Drug User Fees
If you make or sponsor animal drugs, the FDA is setting new user fee rates and payment procedures for fiscal year 2026 that take effect starting October 1, 2025. These fees apply to certain animal drug applications and supplemental applications, certain animal drug products, certain establishments where products are made, and certain sponsors.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16959, Frequently Asked Questions-Developing Potential Cellular and Gene Therapy Products; Final Guidance for Industry; Availability
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance titled "Frequently asked Questions--Developing Potential Cellular and Gene Therapy Products." The guidance document provides industry with answers to frequently asked questions (FAQs) and commonly faced issues that arise during the development of cellular and gene therapy (CGT) products. The FAQs represent common questions directed to the Agency and span multiple disciplines, including regulatory review; chemistry, manufacturing, and controls (CMC); pharmacology/toxicology; clinical; and clinical pharmacology. This guidance announced in this notice finalizes the draft guidance of the same title issued on November 19, 2024.
2026-16939, GNT USA, LLC.; Filing of Color Additive Petition
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by GNT USA, LLC., c/o Exponent, Inc., proposing that we amend our color additive regulations to provide for the safe use of safflower (Carthamus tinctorius L.) extract as a color additive in various foods at levels consistent with good manufacturing practices.
2026-16942, Food Additives Permitted in Feed and Drinking Water of Animals; Chromium DL-methionine Chelate
The Food and Drug Administration (FDA, we, or the Agency) is amending the regulations for food additives permitted in feed and drinking water of animals to provide for the safe use of chromium DL- methionine chelate as a nutritional source of chromium in cattle feed. This action is in response to a food additive petition filed by Zinpro Corp.
Previous / Next Documents
Previous: 2025-14416, Biosimilar User Fee Rates for Fiscal Year 2026
The FDA is setting new fees for companies working on biosimilar drugs in fiscal year 2026. If you’re developing or getting approval for these drugs, expect some updated costs starting October 1, 2025. These fees help the FDA keep reviews speedy and safe, so everyone wins!
Next: 2025-14418, Presidential Declaration of a Major Disaster for the State of West Virginia
West Virginia just got a major disaster declaration after severe storms, flooding, and landslides hit hard. This means extra federal help is on the way to support affected communities and speed up recovery. Residents and local governments should act fast to access aid and rebuild stronger starting now.